FDA Limits on Antibacterial Healthcare Ingredients Could Put Patients, Employee Safety at RiskRead More
Washington, DC, | August 13, 2014 – Analysis of research showing trace elements of antibacterial ingredients in pregnant women and fetuses...MoreRead More
Antibacterial Ingredients Play Beneficial Role in Hygiene and Health for Millions, FDA ToldRead More
Green group’s unscientific attack on soap June 18, 2014 | The Hill Newly proposed rules by the FDA could severely limit or even...MoreRead More
The American Cleaning Institute and the Personal Care Products Council filed detailed comments with the Food and Drug Administration asking for changes in proposed rules governing antibacterial soaps and ingredients. The groups said the FDA’s proposal could eliminate consumer access to these products and “would increase the risk and level of exposure of the general population to bacteria, which could lead to increased infection and disease.”Read More
A: The use of antibacterial soaps does not lead to antibiotic cross-resistance in bacteria. For example, in over 40 years of real world use, there are no known cases or any evidence that triclosan causes resistance in bacteria. Triclosan is an antimicrobial agent that slows or stops the growth of bacteria on surfaces and skin. Triclosan is NOT an antibiotic. It does not treat systemic (inside the body) bacterial infections, which is what antibiotics do. It has been widely recognized throughout the medical community that bacterial resistance is the result of misuse and over-prescription of antibiotic drugs, not the use of triclosan-containing or other antibacterial soaps.
ACI's DeLeo: loss of many healthcare antiseptic products would have serious public health implications.
- Wednesday Sep 3